News Image

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer

Provided By GlobeNewswire

Last update: Dec 17, 2025

Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product

Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore

Read more at globenewswire.com

LIFECORE BIOMEDICAL INC

NASDAQ:LFCR (12/19/2025, 5:56:31 PM)

After market: 8.04 0 (0%)

8.04

-0.38 (-4.51%)



Find more stocks in the Stock Screener

Follow ChartMill for more